Adverum Biotechnologies
ADVM
ADVM
65 hedge funds and large institutions have $67.3M invested in Adverum Biotechnologies in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 58 → 65 (+7)
1.13% more ownership
Funds ownership: 3.14% → 4.27% (+1.1%)
Holders
65
Holding in Top 10
–
Calls
$1.48M
Puts
$131K
Top Buyers
| 1 | +$7.93M | |
| 2 | +$2.8M | |
| 3 | +$2.5M | |
| 4 |
Morgan Stanley
New York
|
+$2.02M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.75M |
Top Sellers
| 1 | -$3.58M | |
| 2 | -$2.79M | |
| 3 | -$1.02M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$561K |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$350K |